Preparation of the registration dossier for the original medicinal product

22 December 2020

CPD provided services under the contract for the preparation of the registration dossier for the original drug.

A phase I study of an innovative drug used in the treatment of patients with a new coronavirus infection (COVID-19) has been completed. The final report has been prepared.

CPD has developed a strategy for preclinical and clinical study of a new prolonged finished dosage form in order to further obtain a registration certificate.

Subscribe to the newsletter of interesting articles and news

Prepa­ra­tion of the regis­tra­tion dossier for the original medicinal product

Preparation of the registration dossier for the original medicinal product